Search

Your search keyword '"Pesavento, R"' showing total 352 results

Search Constraints

Start Over You searched for: Author "Pesavento, R" Remove constraint Author: "Pesavento, R"
352 results on '"Pesavento, R"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

3. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

4. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

5. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

6. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

7. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

8. Timing and characteristics of venous thromboembolism after noncancer surgery

9. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

14. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

16. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

17. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

18. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

19. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

20. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

21. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

22. DVT Management and Outcome Trends, 2001 to 2014

23. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

25. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

26. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

27. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

28. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

29. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

30. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

31. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

32. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

33. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

34. Meta-analyses of sulodexide and other drugs in prevention and treatment of post-thrombotic syndrome.

35. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

36. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

39. Timing and characteristics of venous thromboembolism after noncancer surgery

40. Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

41. Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation (Journal of Thrombosis and Thrombolysis, (2021), 52, 3, (772-778), 10.1007/s11239-021-02429-z)

42. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

43. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study

45. Predictors of active cancer thromboembolic outcomes

46. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

47. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

48. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

49. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

50. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

Catalog

Books, media, physical & digital resources